{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:00:39Z","timestamp":1793703639918,"version":"4.5.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Office of the Permanent Secretary for Higher Education, Science, Research, and Innovation in Thailand","award":["RGNS 63-145"],"award-info":[{"award-number":["RGNS 63-145"]}]},{"name":"Office of the Permanent Secretary for Higher Education, Science, Research, and Innovation in Thailand","award":["RGNS 63-145"],"award-info":[{"award-number":["RGNS 63-145"]}]},{"name":"Thailand Science Research and Innovation Fund, and the University of Phayao","award":["FF66-RIM048"],"award-info":[{"award-number":["FF66-RIM048"]}]},{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"crossref","award":["Aussara Panya"],"award-info":[{"award-number":["Aussara Panya"]}],"id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72833-x","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T17:02:01Z","timestamp":1726765321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Enhancing cancer immunotherapy using cordycepin and Cordyceps militaris extract to sensitize cancer cells and modulate immune responses"],"prefix":"10.1038","volume":"14","author":[{"given":"Chutamas","family":"Thepmalee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phanitaporn","family":"Jenkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boonyanuch","family":"Ramwarungkura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nittiya","family":"Suwannasom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krissana","family":"Khoothiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonthida","family":"Thephinlap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunghathai","family":"Sawasdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aussara","family":"Panya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pa-thai","family":"Yenchitsomanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"72833_CR1","doi-asserted-by":"crossref","unstructured":"Papaioannou, N. E., Beniata, O. V., Vitsos, P., Tsitsilonis, O. & Samara, P. Harnessing the immune system to improve cancer therapy. Annals Translational Med.4, 261, (2016).","DOI":"10.21037\/atm.2016.04.01"},{"key":"72833_CR2","doi-asserted-by":"publisher","unstructured":"Velcheti, V. & Schalper, K. Basic overview of current immunotherapy approaches in cancer. Am. Soc. Clin. Oncol. Educational Book. 298\u2013308. https:\/\/doi.org\/10.1200\/EDBK_156572 (2016).","DOI":"10.1200\/EDBK_156572"},{"key":"72833_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman, A. D., Fritz, J. M. & Lenardo, M. J. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat. Rev. Immunol.20, 651\u2013668. https:\/\/doi.org\/10.1038\/s41577-020-0306-5 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"72833_CR4","doi-asserted-by":"publisher","unstructured":"Koury, J. et al. Immunotherapies: exploiting the immune system for cancer treatment. J. Immunol. Res.2018 (9585614). https:\/\/doi.org\/10.1155\/2018\/9585614 (2018).","DOI":"10.1155\/2018\/9585614"},{"key":"72833_CR5","doi-asserted-by":"publisher","unstructured":"Huo, J. L. et al. Research advance of natural products in tumor immunotherapy. Front. Immunol.13. https:\/\/doi.org\/10.3389\/fimmu.2022.972345 (2022).","DOI":"10.3389\/fimmu.2022.972345"},{"key":"72833_CR6","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.3892\/ol.2018.9219","volume":"16","author":"Y Yu","year":"2018","unstructured":"Yu, Y. & Cui, J. Present and future of cancer immunotherapy: a tumor microenvironmental perspective (review). Oncol. Lett.16, 4105\u20134113. https:\/\/doi.org\/10.3892\/ol.2018.9219 (2018).","journal-title":"Oncol. Lett."},{"key":"72833_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-022-01282-8","volume":"15","author":"Y Tie","year":"2022","unstructured":"Tie, Y., Tang, F., Wei, Y. & Wei, X. Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J. Hematol. Oncol.15, 61. https:\/\/doi.org\/10.1186\/s13045-022-01282-8 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"72833_CR8","doi-asserted-by":"publisher","unstructured":"Nuzzo, G. et al. Antitumor potential of immunomodulatory natural products. Mar. Drugs. 20. https:\/\/doi.org\/10.3390\/md20060386 (2022).","DOI":"10.3390\/md20060386"},{"key":"72833_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.apsb.2021.08.020","volume":"12","author":"S Dong","year":"2022","unstructured":"Dong, S., Guo, X., Han, F., He, Z. & Wang, Y. Emerging role of natural products in cancer immunotherapy. Acta Pharm. Sin B. 12, 1163\u20131185. https:\/\/doi.org\/10.1016\/j.apsb.2021.08.020 (2022).","journal-title":"Acta Pharm. Sin B"},{"key":"72833_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.semcancer.2022.06.009","volume":"86","author":"M Gupta","year":"2022","unstructured":"Gupta, M., Chandan, K. & Sarwat, M. Natural products and their derivatives as immune check point inhibitors: targeting cytokine\/chemokine signalling in cancer. Sem. Cancer Biol.86, 214\u2013232. https:\/\/doi.org\/10.1016\/j.semcancer.2022.06.009 (2022).","journal-title":"Sem. Cancer Biol."},{"key":"72833_CR11","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1111\/cas.14675","volume":"111","author":"T Hayakawa","year":"2020","unstructured":"Hayakawa, T., Yaguchi, T. & Kawakami, Y. Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3. Cancer Sci.111, 4326\u20134335. https:\/\/doi.org\/10.1111\/cas.14675 (2020).","journal-title":"Cancer Sci."},{"key":"72833_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ygyno.2019.09.015","volume":"155","author":"RE O\u2019Cearbhaill","year":"2019","unstructured":"O\u2019Cearbhaill, R. E. et al. A phase II randomized, double-blind trial of a polyvalent vaccine-KLH conjugate (NSC 748933 IND# 14384)\u2009+\u2009OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: an NRG Oncology\/GOG study. Gynecol. Oncol.155, 393\u2013399. https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.015 (2019).","journal-title":"Gynecol. Oncol."},{"key":"72833_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00262-022-03253-x","volume":"72","author":"EA De Jaeghere","year":"2023","unstructured":"De Jaeghere, E. A. et al. Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: results of the phase II PRIMMO study. Cancer Immunol. Immunother. 72, 475\u2013491. https:\/\/doi.org\/10.1007\/s00262-022-03253-x (2023).","journal-title":"Cancer Immunol. Immunother"},{"key":"72833_CR14","doi-asserted-by":"publisher","unstructured":"J\u0119drejko, K. J., Lazur, J. & Muszy\u0144ska, B. Cordyceps militaris: an overview of its chemical constituents in relation to biological activity. Foods. 10. https:\/\/doi.org\/10.3390\/foods10112634 (2021).","DOI":"10.3390\/foods10112634"},{"key":"72833_CR15","doi-asserted-by":"publisher","unstructured":"Phull, A. R., Ahmed, M. & Park, H. J. Cordyceps militaris as a bio functional food source: pharmacological potential, anti-inflammatory actions and related molecular mechanisms. Microorganisms. 10. https:\/\/doi.org\/10.3390\/microorganisms10020405 (2022).","DOI":"10.3390\/microorganisms10020405"},{"key":"72833_CR16","doi-asserted-by":"publisher","first-page":"575704","DOI":"10.3389\/fphar.2020.575704","volume":"11","author":"CT Lee","year":"2020","unstructured":"Lee, C. T. et al. Trends in the immunomodulatory effects of Cordyceps militaris: total extracts, polysaccharides and cordycepin. Front. Pharmacol.11, 575704. https:\/\/doi.org\/10.3389\/fphar.2020.575704 (2020).","journal-title":"Front. Pharmacol."},{"key":"72833_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3746\/jkfn.2012.41.4.494","volume":"41","author":"HJ Kim","year":"2012","unstructured":"Kim, H. J., Lee, T. H., Sam, Y., Son, K., & Kim, C. K. Immunomodulatory activities of ethanol extract of Cordyceps militaris in immunocompromised mice. J. Korean Soc. Food Sci. Nutr.41, 494\u2013500. https:\/\/doi.org\/10.3746\/jkfn.2012.41.4.494 (2012).","journal-title":"J. Korean Soc. Food Sci. Nutr."},{"key":"72833_CR18","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.prmcm.2023.100228","volume":"7","author":"S Shweta, Abdullah","year":"2023","unstructured":"Shweta, Abdullah, S., Kumar, A.\u00a0Komal A.\u00a0 A brief review on the medicinal uses of Cordyceps\u00a0militaris. Pharmacol. Res. - Mod. Chin. Med.7,  100228. https:\/\/doi.org\/10.1016\/j.prmcm.2023.100228 (2023).","journal-title":"Pharmacol. Res. - Mod. Chin. Med."},{"key":"72833_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4110\/in.2010.10.4.135","volume":"10","author":"S Shin","year":"2010","unstructured":"Shin, S. et al. Cordyceps militaris enhances MHC-restricted antigen presentation via the induced expression of MHC molecules and production of cytokines. Immune Netw.10, 135\u2013143. https:\/\/doi.org\/10.4110\/in.2010.10.4.135 (2010).","journal-title":"Immune Netw."},{"key":"72833_CR20","doi-asserted-by":"publisher","unstructured":"Panwong, S. et al. Cordycepin sensitizes cholangiocarcinoma cells to be killed by natural killer-92 (NK-92) cells. Molecules. 26. https:\/\/doi.org\/10.3390\/molecules26195973 (2021).","DOI":"10.3390\/molecules26195973"},{"key":"72833_CR21","doi-asserted-by":"publisher","first-page":"950536","DOI":"10.3389\/fimmu.2022.950536","volume":"13","author":"Y Bai","year":"2022","unstructured":"Bai, Y. et al. Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing. Front. Immunol.13, 950536. https:\/\/doi.org\/10.3389\/fimmu.2022.950536 (2022).","journal-title":"Front. Immunol."},{"key":"72833_CR22","doi-asserted-by":"publisher","unstructured":"Oura, K., Morishita, A., Tani, J. & Masaki, T. Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review. Int. J. Mol. Sci.22.https:\/\/doi.org\/10.3390\/ijms22115801 (2021).","DOI":"10.3390\/ijms22115801"},{"key":"72833_CR23","doi-asserted-by":"publisher","unstructured":"Lee, C. T. et al. Trends in the immunomodulatory effects of Cordycepsmilitaris: total extracts, polysaccharides and cordycepin. Front. Pharmacol.11. https:\/\/doi.org\/10.3389\/fphar.2020.575704 (2020).","DOI":"10.3389\/fphar.2020.575704"},{"key":"72833_CR24","doi-asserted-by":"publisher","first-page":"e0291363","DOI":"10.1371\/journal.pone.0291363","volume":"18","author":"D Zhang","year":"2023","unstructured":"Zhang, D. et al. Antimicrobial, antioxidant, anti-inflammatory, and cytotoxic activities of Cordycepsmilitaris spent substrate. PLOS ONE. 18, e0291363. https:\/\/doi.org\/10.1371\/journal.pone.0291363 (2023).","journal-title":"PLOS ONE"},{"key":"72833_CR25","doi-asserted-by":"publisher","unstructured":"Eiamthaworn, K., Kaewkod, T., Bovonsombut, S. & Tragoolpua, Y. Efficacy of Cordyceps militaris extracts against some skin pathogenic bacteria and antioxidant activity. J. Fungi (Basel). 8. https:\/\/doi.org\/10.3390\/jof8040327 (2022).","DOI":"10.3390\/jof8040327"},{"key":"72833_CR26","first-page":"957","volume":"3","author":"L Huang","year":"2009","unstructured":"Huang, L., Li, Q. Z., Chen, Y., Wang, X. & Zhou, X. Determination and analysis of cordycepin and adenosine in the products of Cordyceps spp. Afr. J. Microbiol. Res.3, 957\u2013961 (2009).","journal-title":"Afr. J. Microbiol. Res."},{"key":"72833_CR27","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.3390\/foods10112634","volume":"10","author":"KJ J\u0119drejko","year":"2021","unstructured":"J\u0119drejko, K. J., Lazur, J. & Muszy\u0144ska, B. Cordycepsmilitaris: an overview of its chemical constituents in relation to biological activity. Foods. 10, 2634 (2021).","journal-title":"Foods"},{"key":"72833_CR28","doi-asserted-by":"publisher","unstructured":"Liu Y, Guo ZJ, Zhou XW. Chinese Cordyceps: bioactive components, antitumor effects and underlying mechanism-A review.Molecules 27, 6576.https:\/\/doi.org\/10.3390\/molecules27196576 (2022).","DOI":"10.3390\/molecules27196576"},{"key":"72833_CR29","doi-asserted-by":"publisher","unstructured":"Turk, A. et al. Adenosine deaminase inhibitory activity of medicinal plants: boost the production of cordycepin in Cordycepsmilitaris. Antioxid. (Basel). 12. https:\/\/doi.org\/10.3390\/antiox12061260 (2023).","DOI":"10.3390\/antiox12061260"},{"key":"72833_CR30","doi-asserted-by":"publisher","first-page":"15760","DOI":"10.1038\/s41598-019-52254-x","volume":"9","author":"JB Lee","year":"2019","unstructured":"Lee, J. B. et al. A novel nucleoside rescue metabolic pathway may be responsible for therapeutic effect of orally administered cordycepin. Sci. Rep.9, 15760. https:\/\/doi.org\/10.1038\/s41598-019-52254-x (2019).","journal-title":"Sci. Rep."},{"key":"72833_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/ijc.10966","volume":"104","author":"M Jinushi","year":"2003","unstructured":"Jinushi, M. et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer. 104, 354\u2013361. https:\/\/doi.org\/10.1002\/ijc.10966 (2003).","journal-title":"Int. J. Cancer"},{"key":"72833_CR32","doi-asserted-by":"publisher","unstructured":"Shankar, K., Capitini, C. & Saha, K. Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies. Stem Cell Res. Ther.11. https:\/\/doi.org\/10.1186\/s13287-020-01741-4 (2020).","DOI":"10.1186\/s13287-020-01741-4"},{"key":"72833_CR33","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF03401808","volume":"3","author":"J O\u2019Connell","year":"1997","unstructured":"O\u2019Connell, J., Bennett, M. W., O\u2019Sullivan, G. C., Collins, J. K. & Shanahan, F. The Fas counterattack: a molecular mechanism of tumor immune privilege. Mol. Med.3, 294\u2013300. https:\/\/doi.org\/10.1007\/BF03401808 (1997).","journal-title":"Mol. Med."},{"key":"72833_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11010-013-1752-1","volume":"383","author":"S Park","year":"2013","unstructured":"Park, S., Cho, D. H., Andera, L., Suh, N. & Kim, I. Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins. Mol. Cell. Biochem.383, 39\u201348. https:\/\/doi.org\/10.1007\/s11010-013-1752-1 (2013).","journal-title":"Mol. Cell. Biochem."},{"key":"72833_CR35","doi-asserted-by":"publisher","first-page":"115286","DOI":"10.1016\/j.biopha.2023.115286","volume":"166","author":"C Thepmalee","year":"2023","unstructured":"Thepmalee, C. et al. Anti-cancer effect of a phytochemical compound \u2013 7R-acetylmelodorinol \u2013 against triple-negative breast cancer cells. Biomed. Pharmacother.166, 115286. https:\/\/doi.org\/10.1016\/j.biopha.2023.115286 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"72833_CR36","doi-asserted-by":"publisher","first-page":"21694","DOI":"10.1074\/jbc.M116.738302","volume":"291","author":"W Yao","year":"2016","unstructured":"Yao, W. et al. Expression of death receptor 4 is positively regulated by MEK\/ERK\/AP-1 signaling and suppressed upon MEK Inhibition. J. Biol. Chem.291, 21694\u201321702. https:\/\/doi.org\/10.1074\/jbc.M116.738302 (2016).","journal-title":"J. Biol. Chem."},{"key":"72833_CR37","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1128\/mcb.25.13.5404-5416.2005","volume":"25","author":"S Shetty","year":"2005","unstructured":"Shetty, S. et al. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. Mol. Cell. Biol.25, 5404\u20135416. https:\/\/doi.org\/10.1128\/mcb.25.13.5404-5416.2005 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"72833_CR38","doi-asserted-by":"publisher","unstructured":"Hazini, A., Fisher, K. & Seymour, L. Deregulation of HLA-I in cancer and its central importance for immunotherapy. J. Immunother Cancer. 9. https:\/\/doi.org\/10.1136\/jitc-2021-002899 (2021).","DOI":"10.1136\/jitc-2021-002899"},{"key":"72833_CR39","first-page":"37","volume":"6","author":"HB Sapan","year":"2016","unstructured":"Sapan, H. B. et al. Pattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome (MODS) in polytrauma. Int. J. Burns Trauma.6, 37\u201343 (2016).","journal-title":"Int. J. Burns Trauma."},{"key":"72833_CR40","doi-asserted-by":"publisher","first-page":"8921","DOI":"10.18632\/oncotarget.13475","volume":"8","author":"K Hientz","year":"2017","unstructured":"Hientz, K., Mohr, A., Bhakta-Guha, D. & Efferth, T. The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget. 8, 8921\u20138946. https:\/\/doi.org\/10.18632\/oncotarget.13475 (2017).","journal-title":"Oncotarget"},{"key":"72833_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/2159-8290.Cd-22-0381","volume":"13","author":"KZ Guiley","year":"2023","unstructured":"Guiley, K. Z. & Shokat, K. M. A small molecule reacts with the p53 somatic mutant Y220C to rescue wild-type thermal stability. Cancer Discov. 13, 56\u201369. https:\/\/doi.org\/10.1158\/2159-8290.Cd-22-0381 (2023).","journal-title":"Cancer Discov"},{"key":"72833_CR42","doi-asserted-by":"publisher","first-page":"14928","DOI":"10.3390\/ijms241914928","volume":"24","author":"J Xing","year":"2023","unstructured":"Xing, J., Zhang, J. & Wang, J. The immune regulatory role of adenosine in the tumor microenvironment. Int. J. Mol. Sci.24, 14928 (2023).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72833-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72833-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72833-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T17:03:34Z","timestamp":1726765414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72833-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72833"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72833-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21907"}}